 | • レポートコード：MRC2Q12-16760 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、創薬CROのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 創薬CROのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 創薬CROの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 創薬CROのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの創薬CROの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の創薬CROの売上および2028年までの予測に焦点を当てています。 創薬CROのグローバル主要企業には、Charles River、Wuxi Apptec、Eurofins Scientific、Pharmaron、Labcorp、ChemPartner、Vivaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 創薬CRO市場は、タイプとアプリケーションによって区分されます。世界の創薬CRO市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 HTS、FBDD、SBDD、その他 【アプリケーション別セグメント】 医薬品、生物製剤 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 創薬CRO製品概要 - タイプ別市場（HTS、FBDD、SBDD、その他） - アプリケーション別市場（医薬品、生物製剤） - 調査の目的 ・エグゼクティブサマリー - 世界の創薬CRO販売量予測2017-2028 - 世界の創薬CRO売上予測2017-2028 - 創薬CROの地域別販売量 - 創薬CROの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別創薬CRO販売量 - 主要メーカー別創薬CRO売上 - 主要メーカー別創薬CRO価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（HTS、FBDD、SBDD、その他） - 創薬CROのタイプ別販売量 - 創薬CROのタイプ別売上 - 創薬CROのタイプ別価格 ・アプリケーション別市場規模（医薬品、生物製剤） - 創薬CROのアプリケーション別販売量 - 創薬CROのアプリケーション別売上 - 創薬CROのアプリケーション別価格 ・北米市場 - 北米の創薬CRO市場規模（タイプ別、アプリケーション別） - 主要国別の創薬CRO市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの創薬CRO市場規模（タイプ別、アプリケーション別） - 主要国別の創薬CRO市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の創薬CRO市場規模（タイプ別、アプリケーション別） - 主要国別の創薬CRO市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の創薬CRO市場規模（タイプ別、アプリケーション別） - 主要国別の創薬CRO市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの創薬CRO市場規模（タイプ別、アプリケーション別） - 主要国別の創薬CRO市場規模（トルコ、サウジアラビア） ・企業情報 Charles River、Wuxi Apptec、Eurofins Scientific、Pharmaron、Labcorp、ChemPartner、Viva ・産業チェーン及び販売チャネル分析 - 創薬CROの産業チェーン分析 - 創薬CROの原材料 - 創薬CROの生産プロセス - 創薬CROの販売及びマーケティング - 創薬CROの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 創薬CROの産業動向 - 創薬CROのマーケットドライバー - 創薬CROの課題 - 創薬CROの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Drug Discovery CRO estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drug Discovery CRO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drug Discovery CRO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drug Discovery CRO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Drug Discovery CRO include Charles River, Wuxi Apptec, Eurofins Scientific, Pharmaron, Labcorp, ChemPartner and Viva, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drug Discovery CRO companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drug Discovery CRO market. Further, it explains the major drivers and regional dynamics of the global Drug Discovery CRO market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Charles River
Wuxi Apptec
Eurofins Scientific
Pharmaron
Labcorp
ChemPartner
Viva
Market Segments
This report has explored the key segments: by Technology and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by technology and by application segments based on value for the period 2017-2028.
Drug Discovery CRO Segment by Technology
HTS
FBDD
SBDD
Others
Drug Discovery CRO Segment by Application
Drug
Biologics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Discovery CRO market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drug Discovery CRO market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drug Discovery CRO, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Discovery CRO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Discovery CRO revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Drug Discovery CRO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Drug Discovery CRO revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River, Wuxi Apptec, Eurofins Scientific, Pharmaron, Labcorp, ChemPartner and Viva, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Discovery CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery CRO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by technology, by application and by country, revenue for each segment.
Chapter 7: Europe by technology, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by technology, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by technology, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by technology, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Discovery CRO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Drug Discovery CRO Market Size Growth Rate by Technology, 2017 VS 2021 VS 2028
1.2.2 HTS
1.2.3 FBDD
1.2.4 SBDD
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Discovery CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drug
1.3.3 Biologics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery CRO Market Perspective (2017-2028)
2.2 Drug Discovery CRO Growth Trends by Region
2.2.1 Drug Discovery CRO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drug Discovery CRO Historic Market Size by Region (2017-2022)
2.2.3 Drug Discovery CRO Forecasted Market Size by Region (2023-2028)
2.3 Drug Discovery CRO Market Dynamics
2.3.1 Drug Discovery CRO Industry Trends
2.3.2 Drug Discovery CRO Market Drivers
2.3.3 Drug Discovery CRO Market Challenges
2.3.4 Drug Discovery CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery CRO Players by Revenue
3.1.1 Global Top Drug Discovery CRO Players by Revenue (2017-2022)
3.1.2 Global Drug Discovery CRO Revenue Market Share by Players (2017-2022)
3.2 Global Drug Discovery CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery CRO Revenue
3.4 Global Drug Discovery CRO Market Concentration Ratio
3.4.1 Global Drug Discovery CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery CRO Revenue in 2021
3.5 Drug Discovery CRO Key Players Head office and Area Served
3.6 Key Players Drug Discovery CRO Product Solution and Service
3.7 Date of Enter into Drug Discovery CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery CRO Breakdown Data by Technology
4.1 Global Drug Discovery CRO Historic Market Size by Technology (2017-2022)
4.2 Global Drug Discovery CRO Forecasted Market Size by Technology (2023-2028)
5 Drug Discovery CRO Breakdown Data by Application
5.1 Global Drug Discovery CRO Historic Market Size by Application (2017-2022)
5.2 Global Drug Discovery CRO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drug Discovery CRO Market Size (2017-2028)
6.2 North America Drug Discovery CRO Market Size by Technology
6.2.1 North America Drug Discovery CRO Market Size by Technology (2017-2022)
6.2.2 North America Drug Discovery CRO Market Size by Technology (2023-2028)
6.2.3 North America Drug Discovery CRO Market Share by Technology (2017-2028)
6.3 North America Drug Discovery CRO Market Size by Application
6.3.1 North America Drug Discovery CRO Market Size by Application (2017-2022)
6.3.2 North America Drug Discovery CRO Market Size by Application (2023-2028)
6.3.3 North America Drug Discovery CRO Market Share by Application (2017-2028)
6.4 North America Drug Discovery CRO Market Size by Country
6.4.1 North America Drug Discovery CRO Market Size by Country (2017-2022)
6.4.2 North America Drug Discovery CRO Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drug Discovery CRO Market Size (2017-2028)
7.2 Europe Drug Discovery CRO Market Size by Technology
7.2.1 Europe Drug Discovery CRO Market Size by Technology (2017-2022)
7.2.2 Europe Drug Discovery CRO Market Size by Technology (2023-2028)
7.2.3 Europe Drug Discovery CRO Market Share by Technology (2017-2028)
7.3 Europe Drug Discovery CRO Market Size by Application
7.3.1 Europe Drug Discovery CRO Market Size by Application (2017-2022)
7.3.2 Europe Drug Discovery CRO Market Size by Application (2023-2028)
7.3.3 Europe Drug Discovery CRO Market Share by Application (2017-2028)
7.4 Europe Drug Discovery CRO Market Size by Country
7.4.1 Europe Drug Discovery CRO Market Size by Country (2017-2022)
7.4.2 Europe Drug Discovery CRO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery CRO Market Size (2017-2028)
8.2 Asia-Pacific Drug Discovery CRO Market Size by Technology
8.2.1 Asia-Pacific Drug Discovery CRO Market Size by Technology (2017-2022)
8.2.2 Asia-Pacific Drug Discovery CRO Market Size by Technology (2023-2028)
8.2.3 Asia-Pacific Drug Discovery CRO Market Share by Technology (2017-2028)
8.3 Asia-Pacific Drug Discovery CRO Market Size by Application
8.3.1 Asia-Pacific Drug Discovery CRO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drug Discovery CRO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drug Discovery CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Drug Discovery CRO Market Size by Region
8.4.1 Asia-Pacific Drug Discovery CRO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drug Discovery CRO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug Discovery CRO Market Size (2017-2028)
9.2 Latin America Drug Discovery CRO Market Size by Technology
9.2.1 Latin America Drug Discovery CRO Market Size by Technology (2017-2022)
9.2.2 Latin America Drug Discovery CRO Market Size by Technology (2023-2028)
9.2.3 Latin America Drug Discovery CRO Market Share by Technology (2017-2028)
9.3 Latin America Drug Discovery CRO Market Size by Application
9.3.1 Latin America Drug Discovery CRO Market Size by Application (2017-2022)
9.3.2 Latin America Drug Discovery CRO Market Size by Application (2023-2028)
9.3.3 Latin America Drug Discovery CRO Market Share by Application (2017-2028)
9.4 Latin America Drug Discovery CRO Market Size by Country
9.4.1 Latin America Drug Discovery CRO Market Size by Country (2017-2022)
9.4.2 Latin America Drug Discovery CRO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery CRO Market Size (2017-2028)
10.2 Middle East & Africa Drug Discovery CRO Market Size by Technology
10.2.1 Middle East & Africa Drug Discovery CRO Market Size by Technology (2017-2022)
10.2.2 Middle East & Africa Drug Discovery CRO Market Size by Technology (2023-2028)
10.2.3 Middle East & Africa Drug Discovery CRO Market Share by Technology (2017-2028)
10.3 Middle East & Africa Drug Discovery CRO Market Size by Application
10.3.1 Middle East & Africa Drug Discovery CRO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drug Discovery CRO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drug Discovery CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Drug Discovery CRO Market Size by Country
10.4.1 Middle East & Africa Drug Discovery CRO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drug Discovery CRO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Drug Discovery CRO Introduction
11.1.4 Charles River Revenue in Drug Discovery CRO Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 Wuxi Apptec
11.2.1 Wuxi Apptec Company Details
11.2.2 Wuxi Apptec Business Overview
11.2.3 Wuxi Apptec Drug Discovery CRO Introduction
11.2.4 Wuxi Apptec Revenue in Drug Discovery CRO Business (2017-2022)
11.2.5 Wuxi Apptec Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Drug Discovery CRO Introduction
11.3.4 Eurofins Scientific Revenue in Drug Discovery CRO Business (2017-2022)
11.3.5 Eurofins Scientific Recent Developments
11.4 Pharmaron
11.4.1 Pharmaron Company Details
11.4.2 Pharmaron Business Overview
11.4.3 Pharmaron Drug Discovery CRO Introduction
11.4.4 Pharmaron Revenue in Drug Discovery CRO Business (2017-2022)
11.4.5 Pharmaron Recent Developments
11.5 Labcorp
11.5.1 Labcorp Company Details
11.5.2 Labcorp Business Overview
11.5.3 Labcorp Drug Discovery CRO Introduction
11.5.4 Labcorp Revenue in Drug Discovery CRO Business (2017-2022)
11.5.5 Labcorp Recent Developments
11.6 ChemPartner
11.6.1 ChemPartner Company Details
11.6.2 ChemPartner Business Overview
11.6.3 ChemPartner Drug Discovery CRO Introduction
11.6.4 ChemPartner Revenue in Drug Discovery CRO Business (2017-2022)
11.6.5 ChemPartner Recent Developments
11.7 Viva
11.7.1 Viva Company Details
11.7.2 Viva Business Overview
11.7.3 Viva Drug Discovery CRO Introduction
11.7.4 Viva Revenue in Drug Discovery CRO Business (2017-2022)
11.7.5 Viva Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer